User profiles for Samreen Ijaz

Samreen Ijaz

Unit Head, Blood Borne Virus Unit, UK Health Security Agency
Verified email at ukhsa.gov.uk
Cited by 14484

[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses

…, EM Harrison, JA Hiscox, AYW Ho, PW Horby, S Ijaz… - Cell, 2022 - cell.com
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …

Hepatitis e

…, R Bendall, F Legrand-Abravanel, NS Xia, S Ijaz… - The Lancet, 2012 - thelancet.com
Hepatitis E virus (HEV) was discovered during the Soviet occupation of Afghanistan in the
1980s, after an outbreak of unexplained hepatitis at a military camp. A pooled faecal extract …

Hepatitis E: an emerging infection in developed countries

HR Dalton, R Bendall, S Ijaz, M Banks - The Lancet infectious …, 2008 - thelancet.com
Hepatitis E is endemic in many developing countries where it causes substantial morbidity.
In industrialised countries, it is considered rare, and largely confined to travellers returning …

Persistent carriage of hepatitis E virus in patients with HIV infection

…, FE Keane, RS Tedder, S Ijaz - New England Journal …, 2009 - Mass Medical Soc
To the Editor: Hepatitis E virus is an emerging infection in developed countries, with many
clinical manifestations. We describe a 48-year-old bisexual white male who was infected with …

[HTML][HTML] Hepatitis E virus in blood components: a prevalence and transmission study in southeast England

PE Hewitt, S Ijaz, SR Brailsford, R Brett, S Dicks… - The Lancet, 2014 - thelancet.com
Background The prevalence of hepatitis E virus (HEV) genotype 3 infections in the English
population (including blood donors) is unknown, but is probably widespread, and the virus …

[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …

…, JA Hiscox, AYW Ho, PW Horby, S Ijaz… - The Lancet …, 2021 - thelancet.com
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …

Transfusion‐transmitted hepatitis E in a 'nonhyperendemic'country

…, G Kochethu, G Pratt, D Adams, S Ijaz… - Transfusion …, 2006 - Wiley Online Library
Indigenous hepatitis E is increasingly recognized in developed countries, where it may be a
zoonosis. We describe the first case of transfusion‐transmitted hepatitis E in the UK from a …

[HTML][HTML] Hepatitis E virus and neurologic disorders

…, JM Mansuy, L Rostaing, F Keane, S Ijaz… - Emerging infectious …, 2011 - ncbi.nlm.nih.gov
Abstract Information about the spectrum of disease caused by hepatitis E virus (HEV)
genotype 3 is emerging. During 2004–2009, at 2 hospitals in the United Kingdom and France, …

[HTML][HTML] Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

…, T Fletcher, JA Hiscox, AYW Ho, S Ijaz… - The Lancet …, 2021 - thelancet.com
Background Prognostic models to predict the risk of clinical deterioration in acute COVID-19
cases are urgently required to inform clinical management decisions. Methods We …

A comparison of two commercially available anti‐HEV IgG kits and a re‐evaluation of anti‐HEV IgG seroprevalence data in developed countries

R Bendall, V Ellis, S Ijaz, R Ali… - Journal of medical …, 2010 - Wiley Online Library
In developed countries, the incidence of hepatitis E virus (HEV) infection and the resulting
seroprevalence are uncertain. Published estimates of seroprevalnce in these populations …